Skip to main content

60 Degrees Pharmaceuticals, Inc.

SXTP
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001946563

No open-market purchases or sales by 60 Degrees Pharmaceuticals, Inc. insiders were filed in the last 90 days; 8 institutions reported holding it in 13F filings for Q2 2026, worth $614.8K in total; no superinvestor holds it.

Other share classesSXTPW

Q4 2024 vs. Q3 2024

How the institutions holding 60 Degrees Pharmaceuticals, Inc. changed between Q3 2024 and Q4 2024.

All holders in Q4 2024All holders in Q3 2024

13F holders of SXTP: Q3 2024 compared with Q4 2024
MeasureQ3 2024Q4 2024Change
Holders79+2
Shares32.9K153.7K+120.8K (+366.6%)
Value$41.4K$198.0K+$156.6K (+378.0%)

New holders (5)

Institutions that held 60 Degrees Pharmaceuticals, Inc. at the end of Q4 2024 but not at the end of Q3 2024.

Institutions new to SXTP in Q4 2024
InstitutionSharesValue% of portfolio
Armistice Capital, LLC98,934$127.6K0.00%
Two Sigma Securities, LLC15,444$19.9K0.00%
HRT Financial LP12,591$16.0K0.00%
Bogart Wealth, LLC700$9030.00%
Advisor Group Holdings, Inc.500$6450.00%

Sold out (3)

Institutions that held 60 Degrees Pharmaceuticals, Inc. at the end of Q3 2024 and filed for Q4 2024 without it.

Institutions that sold out of SXTP in Q4 2024
InstitutionShares, Q3 2024Value, Q3 2024
Virtu Financial LLC12,678$16.0K
Citadel Advisors LLC10,095$12.7K
National Bank of Canada4,000$5.00K